331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster II

Association of delayed platelet recovery and lower nadir counts with adverse outcomes in heparin induced thrombocytopenia

HIT or miss Long term outcomes of direct thrombin inhibitors vs fondaparinux use in heparin induced thrombocytopenia

A case series of pediatric patients with congenital thrombotic thrombocytopenia purpura cTTP treated with recombinant ADAMTS13

Thrombotic microangiopathy among hospitalized patients Demographic characteristics diagnostic trends and resource use from a national database study

JMJD1C mediated epigenetic control of HIT antibody production

Aspirin use among patients with thrombotic antiphospholipid antibody syndrome

Embolic stroke of undetermined source with low ADAMTS13 level without evidence of microangiopathic hemolytic anemia case series from single center experience

Comparison of outcomes in antiphospholipid syndrome diagnosed by ISTH versus EULAR criteria

Mortality in immune TTP remains unpredictable Shortcomings of prediction models despite machine learning advances

Retrospective analysis of mortality and morbidity among thrombotic thrombocytopenia purpura presenting to Georgia cancer center

An updated systematic review and meta analysis of caplacizumab for immune thromboticthrombocytopenic purpura Insights into efficacy and safety